首页 | 本学科首页   官方微博 | 高级检索  
     


High glucose‐ROS conditions enhance the progression in cholangiocarcinoma via upregulation of MAN2A2 and CHD8
Authors:Unchalee Thonsri  Sopit Wongkham  Chaisiri Wongkham  Shinjiro Hino  Mitsuyoshi Nakao  Sittiruk Roytrakul  Tomoaki Koga  Wunchana Seubwai
Affiliation:1. Faculty of Medicine, Department of Biochemistry, Khon Kaen University, Khon Kaen Thailand ; 2. Cholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen Thailand ; 3. Department of Medical Cell Biology, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto Japan ; 4. National Center for Genetic Engineering and Biotechnology (BIOTEC), Pathum Thani Thailand ; 5. Faculty of Medicine, Department of Forensic Medicine, Khon Kaen University, Khon Kaen Thailand
Abstract:Diabetes is a major risk factor in the development and progression of several cancers including cholangiocarcinoma (CCA). However, the molecular mechanism by which hyperglycemia potentiates progression of CCA is not clearly understood. Here, we showed that a high glucose condition significantly increased reactive oxygen species (ROS) production and promoted aggressive phenotypes of CCA cells, including proliferation and migration activities. Mannosidase alpha class 2a member 2 (MAN2A2), was upregulated at both mRNA and protein levels in a high glucose‐ and ROS‐dependent manner. In addition, cell proliferation and migration were significantly reduced by MAN2A2 knockdown. Based on our proteome and in silico analyses, we further found that chromodomain helicase DNA‐binding protein 8 (CHD8) was induced by ROS signaling and regulated MAN2A2 expression. Overexpression of CHD8 increased MAN2A2 expression, while CHD8 knockdown dramatically reduced proliferation and migration as well as MAN2A2 expression in CCA cells. Moreover, both MAN2A2 and CHD8 were highly expressed with positive correlation in CCA tumor tissues. Collectively, these data suggested that high glucose conditions promote CCA progression through ROS‐mediated upregulation of MAN2A2 and CHD8. Thus, glucose metabolism is a promising therapeutic target to control tumor progression in patients with CCA and diabetes.
Keywords:CHD8   cholangiocarcinoma   high glucose   MAN2A2   reactive oxygen species
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号